Company intelligence / Profile preview

Milky Way Life Sciences

Ownership: Private
Employees: ~8
Development stage: Preclinical

Overview

Milky Way Life Sciences develops colostrum-based medical nutrition products aimed at boosting immunity, improving gut health, and treating various diseases. Their work leverages the high nutrient content and bioactive compounds in bovine colostrum. Clinical studies are ongoing for several indications including gastrointestinal diseases and immune-related conditions. The company has raised $8 million in its first funding round from YeGu Investments (China) and TaoTe Technology (US)[7].

Therapeutic areas: OncologyEndocrinologyImmunologyGastroenterologyInfectious Diseases
Modalities: Nutritional therapeuticsBiologics (colostrum-derived proteins)
Industry: Biotech

Partnerships

YeGu Investments (China)TaoTe Technology (US)[7]

Beyond the preview

Go deeper on Milky Way Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Milky Way Life Sciences.

Explore the full profile